|
|
|
|
| |
|
 |
About Us
Apimeds is a biomedical company established in September, 2003. Over the last 20 years of R&D on MS, Pain & Inflammation, Apimeds has already established a global level of technology and product development through continuous research and product development efforts on three business fields of bio-pharmaceuticals, animal drugs and medical devices.
In the bio-pharmaceutical area, apitox, approved as the 6th new drug, and as New Biological Drug from Korea FDA in 2003, is already on the market ...
|
|
 |
|
|
|
|
|
|
|
|
|
|